Human papillomavirus infection and invasive cervical neoplasia: A study of prevalence and morphology

Journal of Pathology

Volumn 181, Issue 3, 1997, Pages 270-275

  Zehbe, Ingeborg ^a   Wilander, Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical carcinoma; HPV; Human papillomavirus; Polymerase chain reaction; Single strand conformation polymorphism

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0030954121     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199703)181:3<270::AID-PATH767>3.0.CO;2-R     Document Type: Article

References (44)

1. Syrjänen KJ. Epidemiology of human papillomavirus (HPV) infections and their association with genital squamous cell cancer. APMIS 1989; 97: 957-970.
2. Reeves WC, Brinton LA, Garcia M. et al. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 1989; 32: 1427-1431.
3. Villa LL, Franco ELF. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst 1989; 81: 332-340.
4. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-197.
5. Zur Hausen H. The role of papillomaviruses in anogenital cancer. Scand J Infect Dis 1990; 69(Suppl): 107-111.
6. Zur Hausen H. Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix? (Letter). hit J Cancer 1995; 63: 315-316.
7. De Villiers E-M. Human pathogenic papillomaviruses: an update. In: zur Hausen H, ed. Current Topics in Microbiology. Vol. 86. 1994; 1-12.
8. Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association , between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990; 335: 1171-1174.
9. Resnick RM, Cornelissen MTE, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens. J Natl Cancer Inst 1990; 82: 1477-1484.
10. Peng HQ, Liu SL, Mann V, et al. HPV types 16 and 33, herpes simplex virus type 2, and other risk factors in cervical cancer in Sechuan Province, China. Int J Cancer 1991; 47: 711-716.
11. Van den Brule AJC, Walboomers JMM, du Maine M, Kenemans P, Meijer CJLM. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991; 48: 404-408.
12. Hagmar B, Johansson B, Kalantari M, Petersson Z, Skyldberg B, Walaas L. The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother 1992; 9: 113-117.
13. Muñoz N, Bosch FX, De Sanjosé S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52: 743-749.
14. Ter Meulen J. Eberhardt HC, Luande J, et al. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992; 51: 515-521.
15. Das BC, Sharma JK, Gopalkrishna V, et al. A high frequency of human papillomavirus DNA sequences in cervical carcinoma of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 1992; 36: 239-245.
16. Lörincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Genecol 1992; 79: 328-337.
17. Park DJ, Wilczynski SP, Paquette RL, Miller CW, Koeffler HP. p53 mutations in HPV-negative cervical carcinoma. Oncogene 1994; 9: 205-210.
18. Samoylova EV, Shaikhaiev GO, Petrov SV, Kisseljova NP, Kisseljov FL. HPV infection in cervical-cancer cases in Russia. Int J Cancer 1995; 61: 337-341.
19. Karlsen F, Kristensen G, Holm R, Chitemerere M, Berner A, Hagmar BM. High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primer, and detecting viral genomes with putative deletions. Eur J Cancer 1995; 31A: 1511-1516.
20. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
21. Morrison EAB, Ho GYF, Vermund SH. et al. Human papillomavirus infection and other risk factors for cervical neoplasia: a case - control study. Int J Cancer 1991: 49: 5-13.
22. Matsukura M, Sugase M. Identification of genital human papillomavirus in cervical biopsy specimens: segregation of specific virus types in specific clinicopathological lesions. Int J Cancer 1995; 61: 13-22.
23. Olsen AO, Gjoøen K, Sauer T. et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case - control study. Int J Cancer 1995; 61: 312-315.
24. Zehbe I, Rylander E, Edlund K, Wadell G, Wilander E. Presence of human papillomavirus in cervical intra-epithelial neoplasia using in situ hybridization and various polymerase chain reaction techniques. Virchows Arch 1996; 428: 151-157.
25. Poulson HE, Taylor CW, Sobin LH. Histologic Typing of Female Genital Tumors. Geneva: WHO. 1975.
26. Lungu O, Wright TC Jr, Silverstein S. Typing of human papillomavirus by polymerase chain reaction amplification with L1 consensus primer and RFLP analysis. Mol Cell Probes 1992; 6: 145-152.
27. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
28. De Roda Husman A-M, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection ty PCR. J Gen Virol 1995; 76: 1057-1062.
29. Zehbe I, Sällström JF, Evander M, et al. Non-radioisotopic detection of human papillovirus by using polymerase chain reaction and single-strand conformation polymorphism (PCR-SSCP). Am J Surg Pathol B Diagn Mol Pathol 1996; 5: 206-213.
30. Jeon S, Allen-Hoffmann BL, Lambert PE. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995; 69: 2989-2997.
31. Wagatsuma M, Hashimoto K, Matsukura T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancer: amplification of viral sequences together with cellular flanking sequences. J Virol 1990; 64: 813-821.
32. Pontén J, Adami H-O, Friberg L-G, et al. HPV and cervical cancer (Letter). Int J Cancer 1995; 63: 317.
33. Pontén J, Adami A-O, Bergström R, et al. Strategies for global control of cervical cancer. Int J Cancer 1995; 60: 1-26.
34. Wank R, Thompson C. High risk of squamous cell carcinoma for women with HLA-DQW3. Nature 1991; 352: 723-725.
35. Gregoire L, Lawrence WD, Kukuruga D, et al Association between HLA-DQB alleles and risk for cervical cancer in African - American women. Int J Cancer 1994; 57: 504-507.
36. Dürst M, Gallahan D, Gilbert J, Rhim JS. Glucocorticoid-enhanced neoplastic transformation of human keratynocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 1989; 173: 767-771.
37. Pei XF, Meck JM, Greenhalgh D, Schlegel R. Cotransfection of HPV-18 and v-fos DNA induces tumorigenicity of primary human keratinocytes. Virology 1993; 196: 855-860.
38. Scheffner M, Werness BA, Huibreggste JM, Levine AJ, Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136.
39. Goodrich DW, Lee WH. Molecular characterization of the retinoblastoma susceptibility gene. Biochem Biophys Acta 1993; 1155: 43-61.
40. Tommasino M, Adamczewski JP, Carlotti F, et al. HPV16E7 protein association with protein kinase p33CDK2 and cyclin A. Oncogene 1993; 8: 195-202.
41. Chen JJ, Reid CE, Androphy EJ, Papillomavirus E6 oncoproteins interact with a novel cellular protein. 14th International Papillomavirus Conference. Quebec, Canada. 1995; Abstract 148.
42. Alvarez-Salas LM, Wilczynski SP, Burger RA, Monk BJ, DiPaolo JA. Polymorphism of the HPV-16E6 gene of cervical carcinoma. Int J Oncol 1995; 7: 261-266.
43. Fujinaga Y, Okazawa K, Nishikaua A, et al. Sequence variation of human papillomavirus type 16E7 in preinvasive and invasive cervical neoplasias. Virus Genes 1994; 9: 85-92.
44. Dong X-P, Stubenrauch F, Beyer-Finkler E, Pfister H. Prevalence of deletions of YY1-binding sites in episomal HPV16 DNA from cervical cancers. Int J Cancer 1994; 58: 803-808.